Atika Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-97,500
Closed -$6.66M 95
2023
Q2
$6.66M Buy
97,500
+48,922
+101% +$3.16M 0.67% 53
2023
Q1
$2.35M Sell
48,578
-42,600
-47% -$2.25M 0.35% 65
2022
Q4
$5.49M Buy
+91,178
New +$5.34M 0.79% 43
2021
Q4
Sell
-224,600
Closed -$16M 119
2021
Q3
$16M Sell
224,600
-9,400
-4% -$584K 0.95% 34
2021
Q2
$12M Buy
234,000
+216,094
+1,207% +$6.74M 0.95% 41
2021
Q1
$450K Buy
+17,906
New +$337K 0.04% 89
2016
Q1
Sell
-15,000
Closed -$1.02M 56
2015
Q4
$1.02M Buy
+15,000
New +$905K 0.53% 46
2014
Q2
Sell
-57,500
Closed -$2.2M 75
2014
Q1
$2.2M Buy
57,500
+20,000
+53% +$645K 1.88% 20
2013
Q4
$995K Buy
+37,500
New +$941K 0.88% 44

Other funds holding PRTA

Atika Capital Management's PRTA Position: Q3 2023 in Review

Atika Capital Management sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 97,500 shares — an estimated $6.66M sold.

Atika Capital Management first reported a position in PRTA in Q4 2013 and held it in 9 quarters. The position peaked at $16M in Q3 2021. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

  • Atika Capital Management reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
  • Atika Capital Management sold 97,500 Prothena Corp shares in Q3 2023, an estimated $6.66M.
  • Atika Capital Management first reported a position in Prothena Corp in Q4 2013 and held it in 9 quarters.
  • Atika Capital Management's Prothena Corp position peaked at $16M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on Atika Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.